Clincosm LogoSign in Get a demo

metabolism and nutrition disorder

Showing 26 - 49 of 49
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metabolism and Nutrition Disorder, Obesity Trial in Baltimore (NNC9204-1706 A, Placebo)

Completed
  • Metabolism and Nutrition Disorder
  • Obesity
  • NNC9204-1706 A
  • Placebo
  • Baltimore, Maryland
    Novo Nordisk Investigational Site
Oct 4, 2018

Metabolism and Nutrition Disorder, Obesity Trial in San Antonio (NNC0194-0499, Placebo)

Completed
  • Metabolism and Nutrition Disorder
  • Obesity
  • San Antonio, Texas
    Novo Nordisk Investigational Site
Sep 3, 2018

Metabolism and Nutrition Disorder, Obesity Trial in Baltimore (NNC9204-1177, Placebo)

Completed
  • Metabolism and Nutrition Disorder
  • Obesity
  • Baltimore, Maryland
    Novo Nordisk Investigational Site
Sep 3, 2018

Metabolism and Nutrition Disorder, Obesity Trial in Tempe, Lincoln (NNC9204-0530, liraglutide, )

Completed
  • Metabolism and Nutrition Disorder
  • Obesity
  • Tempe, Arizona
  • +1 more
Sep 3, 2018

Metabolism and Nutrition Disorder, Obesity Trial in Tempe (NNC0165-1562, )

Completed
  • Metabolism and Nutrition Disorder
  • Obesity
  • Tempe, Arizona
    Novo Nordisk Investigational Site
Jul 12, 2018

Metabolism and Nutrition Disorder, Obesity Trial in Hellerup (liraglutide, )

Completed
  • Metabolism and Nutrition Disorder
  • Obesity
  • Hellerup, Denmark
    Novo Nordisk Investigational Site
Jun 26, 2018

Metabolism and Nutrition Disorder, Obesity Trial in Overland Park (NNC0174-0833, Placebo)

Completed
  • Metabolism and Nutrition Disorder
  • Obesity
  • Overland Park, Kansas
    Novo Nordisk Investigational Site
Jan 31, 2018

Metabolism and Nutrition Disorder, Obesity Trial in Overland Park (NNC0174-0833, )

Completed
  • Metabolism and Nutrition Disorder
  • Obesity
  • Overland Park, Kansas
    Novo Nordisk Investigational Site
Jan 23, 2018

Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, )

Completed
Has Results
  • Metabolism and Nutrition Disorder
  • Obesity
  • Birmingham, Alabama
  • +225 more
Dec 20, 2017

Metabolism and Nutrition Disorder, Obesity Trial in Tempe, Lincoln (NNC9204-0530, )

Completed
  • Metabolism and Nutrition Disorder
  • Obesity
  • Tempe, Arizona
  • +1 more
Jan 5, 2018

Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, )

Completed
Has Results
  • Metabolism and Nutrition Disorder
  • Obesity
  • Vestavia Hills, Alabama
  • +160 more
Dec 6, 2017

Diabetes, Metabolism and Nutrition Disorder, Obesity Trial in Leeds (semaglutide, )

Completed
  • Diabetes
  • +2 more
  • Leeds, United Kingdom
    Novo Nordisk Investigational Site
Nov 30, 2017

Metabolism and Nutrition Disorder, Obesity Trial in Canada, United States (liraglutide, )

Completed
Has Results
  • Metabolism and Nutrition Disorder
  • Obesity
  • Goodyear, Arizona
  • +36 more
Sep 29, 2017

Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, orlistat, )

Completed
Has Results
  • Metabolism and Nutrition Disorder
  • Obesity
  • Edegem, Belgium
  • +18 more
Sep 29, 2017

Metabolism and Nutrition Disorder, Obesity, Obstructive Sleep Apnoea Trial in Canada, United States (liraglutide, )

Completed
Has Results
  • Metabolism and Nutrition Disorder
  • +2 more
  • Glendale, California
  • +41 more
Sep 29, 2017

Type2 Diabetes, Weight Loss, Insulin Sensitivity Trial in Uppsala (Gastric by-pass surgery, Low-caloric diet)

Unknown status
  • Type2 Diabetes
  • +5 more
  • Gastric by-pass surgery
  • Low-caloric diet
  • Uppsala, Sweden
    Uppsala univeristy hospital
Oct 25, 2017

Metabolism and Nutrition Disorder Trial (Breakfast, exercise)

Completed
  • Metabolism and Nutrition Disorder
  • Breakfast
  • exercise
  • (no location specified)
Aug 4, 2017

Metabolism and Nutrition Disorder, Obesity Trial in Evansville (NNC 0070-0002-0453, '2-0453, )

Terminated
  • Metabolism and Nutrition Disorder
  • Obesity
  • NNC 0070-0002-0453
  • +2 more
  • Evansville, Indiana
    Novo Nordisk Investigational Site
Jul 25, 2017

Metabolism and Nutrition Disorder, Obesity Trial in Overland Park (NNC9204-0530, liraglutide, )

Completed
  • Metabolism and Nutrition Disorder
  • Obesity
  • Overland Park, Kansas
    Novo Nordisk Investigational Site
Jul 25, 2017

Metabolism and Nutrition Disorder, Obesity Trial in Maastricht (liraglutide)

Completed
  • Metabolism and Nutrition Disorder
  • Obesity
  • Maastricht, Netherlands
    Novo Nordisk Investigational Site
Jul 25, 2017

Metabolism and Nutrition Disorder, Obesity Trial in Evansville, Madison (NNC 0070-0002-0182, )

Terminated
  • Metabolism and Nutrition Disorder
  • Obesity
  • NNC 0070-0002-0182
  • placebo
  • Evansville, Indiana
  • +1 more
Dec 22, 2016

Metabolism and Nutrition Disorder, Obesity Trial in Hannover (liraglutide, )

Completed
  • Metabolism and Nutrition Disorder
  • Obesity
  • Hannover, Germany
    Novo Nordisk Investigational Site
Dec 21, 2016

Metabolism and Nutrition Disorder, Obesity Trial in Neuss (liraglutide)

Completed
  • Metabolism and Nutrition Disorder
  • Obesity
  • Neuss, Germany
    Novo Nordisk Investigational Site
Dec 8, 2016

Metabolism and Nutrition Disorder, Obesity Trial (NNC 0070-0002-0349, )

Withdrawn
  • Metabolism and Nutrition Disorder
  • Obesity
  • NNC 0070-0002-0349
  • placebo
  • (no location specified)
Oct 16, 2014